Abstracts

The Outcome of Transpelvic Magnetic Stimulation (TPMS) in treating Women with Urinary Incontinence and Overactive Bladder – A Prospective Observational Study

PGY 03 / Gynaecology

Zalina Nusee1, Rozihan Ismail3, Nazura Karim2,3, Razman Mohd Rus4
1Department of Obstetrics & Gynecology, International Islamic University Malaysia
2Department of Obstetrics & Gynecology, Hospital Tuanku Ja’afar, Seremban
3Department of Obstetrics & Gynecology, Hospital T. A. Afzan, Kuantan, Pahang
4Department of Community Medicine, International Islamic University Malaysia

Introduction: Pelvic floor muscle therapy (PFMT) is the simplest said to be and the most effective treatment provided that it is done properly and the women is motivated and continue doing it well. Women who are not able to effectively contract their pelvic floor muscle, Transpelvic Magnetic Stimulation (TPMS) is one of the new treatment modalities which is useful.

Objectives: To determine the outcome of TPMS therapy as conservative management in the treatment of female Urinary Incontinence (UI), mixed incontinence and Over Active Bladder (OAB).

Methods: This is a pilot study on 53 women who attended the Urogynaecology clinic diagnosed UI and OAB. They received 10 course of individualized PFMT using TPMS chair over 5 weeks duration which consist of 8 sec pulses followed by 4 sec rest for a total of 20 minutes. They were assessed prior to recruitment, at 5 weeks and 6 months after treatment. Assessments include cough stress test, bladder diary, 1 hour pad test, perineometry and validated questionnaires (UDI 6 or V-8 OAB). The outcomes measures includes objective cure of UI by negative pad test, changes in muscle power, reduction in numbers of leaking episodes, daytime frequency and nocturia, negative cough stress test and improvement in specific quality of life questionnaires (QOL). The analysis was based on intention to treat using SPSS software.

Results: There were total of 53 women recruited in the study. Only 43 of them completed all treatment. Table 1 showed patient’s clinical characteristic. At 6 weeks of treatment, all participants with SUI improved in their severity index followed by OAB (75%) and mixed incontinence group (55.6%). However the percentage dropped 6 months later which was 12.5%, 50% and 44.4% respectively. These were further supported by the perineal muscles power which was improved in SUI and OAB groups at 6 weeks of treatment but deteriorate 6 months later (table 2). Similar findings were seen in the 1 hour pad test and QOL score (table 3). OAB and MIXED groups showed more positive and sustainable outcome of QOL (V8 and UDI 6) compared to SUI. 

Conclusion: TPMS is an effective type of PFMT for UI and OAB. Further study with bigger sample size, longer duration with maintenance therapy is required to see the sustainable effect of the treatment.